All three models highlight Tesla's Q1 earnings beat and improved 21.1% gross margin as a fundamental floor, supported by a technical structure holding above the 20 and 50 SMAs and key support at $383.43. Two models emphasize the commercial momentum from the 370-unit Tesla Semi order and AI/robotics investments as catalysts for a push through the $394.73-$396.86 resistance toward the $400-$407 range. One model uniquely notes that cross-asset confirmation from XLY and TLT strengthens the risk-on path over a 1-3 week horizon.
All three models warn of a potential reversal due to decelerating momentum and dense overhead resistance between $394.73 and $396.86, exacerbated by regulatory headwinds regarding FSD safety in Europe. Two models flag a stretched valuation, specifically citing a 360.1 P/E ratio and a massive $25 billion capex path that threatens negative free cash flow through 2026. Unique technical targets include a retest of the $375.06 volume node or a deeper rotation toward $365 if the NHTSA recall and fading MACD histogram trigger a rejection.
TSLA still has a workable long swing setup if it can be bought on a pullback into the 4h/1d support cluster around the mid-380s, where price remains above the 20 and 50 SMAs on both key timeframes and the post-earnings margin improvement/AI-capex narrative is keeping the higher-timeframe structure constructive. The stock is currently mid-range and only a few dollars below nearby 4h/1d resistance, so the cleaner long is a retest entry rather than chasing; from that location, a push through 394.73-396.86 can open a move toward the low-400s and the thin volume area near 400-407 over the next 1-3 weeks. Cross-asset confirmation from XLY and TLT adds support to the risk-on transmission path, while no immediate event risk reduces the odds of a sudden thesis-breaking catalyst during the holding window.
TSLA is trading in a mid-range to slightly extended area just under dense 4h/1d resistance at $394.73- $396.86, while momentum is decelerating on both the 4h and daily timeframes with falling RSI and a fading positive MACD histogram. Fresh negative news around the NHTSA recall, EU FSD regulatory skepticism, and the market's need to digest a much heavier 2026 capex path with likely negative free cash flow create a plausible catalyst for rejection near resistance and a swing back toward lower value-area support. In a short swing, the setup is less about trend collapse and more about fading a weakening rally into overhead supply before price rotates back toward the $370s.
Tesla's recent Q1 earnings beat and improved gross margin to 21.1% provide fundamental support for upside, while the stock holds above key 4h support at $383.43 with price trading above both SMA20 and SMA50. Fresh commercial momentum from the 370-unit Tesla Semi order by WattEV confirms demand for its energy and trucking ecosystem, acting as a near-term catalyst. Despite regulatory headwinds in Europe, the U.S. remains supportive, and price is positioned to test the $394.73 resistance with potential extension toward $400 if volume reaccelerates.
Tesla is positioned for downside following a surge in capital expenditures to over $25 billion, which will drive negative free cash flow for the remainder of 2026, undermining its stretched valuation. Despite a recent earnings beat, the stock is extended at resistance with fading momentum across multiple timeframes and faces immediate technical resistance at $394.73. The combination of deteriorating fundamentals, regulatory headwinds in Europe, and weak volume confirmation sets up a high-probability reversal, with price expected to retest the major volume node at $375.06 within the next 1-3 weeks.
TSLA's strong earnings report and improving fundamentals, combined with the bullish market regime and supportive technical structure, provide a solid foundation for a long trade. The recent surge in commercial momentum, including the landmark order for 370 Tesla Semis, and the company's investments in AI and robotics, position TSLA for potential long-term growth.
TSLA's valuation is stretched with a P/E ratio of 360.1, and the recent earnings surprise of 17.1% may not be sustainable. The stock is also facing regulatory headwinds with the EU probing FSD safety and branding. With the stock trading above its 50-day SMA and RSI at 54.96, a short position can be taken with a target at $365 and a stop at $405.